SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'RAB'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_A_ADNA601_1 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62ASP A 139LYS A 229ASP A 233LEU A 388 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.35A | 1d4fA-3glqA:57.2 | 1d4fA-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_A_ADNA601_1 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.44A | 1d4fA-3glqA:57.2 | 1d4fA-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_A_ADNA601_2 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | THR A 67GLU A 199THR A 200HIS A 344HIS A 394 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 ( 3.6A) | 0.62A | 1d4fA-3glqA:57.2 | 1d4fA-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_B_ADNB602_1 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62ASP A 139LYS A 229ASP A 233LEU A 388 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.42A | 1d4fB-3glqA:57.2 | 1d4fB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_B_ADNB602_1 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | LEU A 61HIS A 62ASP A 139LYS A 229ASP A 233HIS A 344LEU A 385LEU A 388GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.48A | 1d4fB-3glqA:57.2 | 1d4fB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_B_ADNB602_2 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | THR A 64THR A 67GLU A 199THR A 200HIS A 394 | RAB A 602 (-2.7A)RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)NAD A 601 ( 3.6A) | 0.69A | 1d4fB-3glqA:57.2 | 1d4fB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_C_ADNC603_1 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62ASP A 139LYS A 229ASP A 233LEU A 388 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.41A | 1d4fC-3glqA:57.0 | 1d4fC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_C_ADNC603_1 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.34A | 1d4fC-3glqA:57.0 | 1d4fC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_C_ADNC603_1 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233LEU A 385GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.48A | 1d4fC-3glqA:57.0 | 1d4fC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_C_ADNC603_2 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | THR A 67GLU A 199THR A 200HIS A 344LEU A 388 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A) | 0.67A | 1d4fC-3glqA:57.0 | 1d4fC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_D_ADND604_1 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62ASP A 139LYS A 229ASP A 233LEU A 388 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.46A | 1d4fD-3glqA:56.9 | 1d4fD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_D_ADND604_1 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.50A | 1d4fD-3glqA:56.9 | 1d4fD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1D4F_D_ADND604_2 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | THR A 67GLU A 199THR A 200HIS A 344HIS A 394 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 ( 3.6A) | 0.64A | 1d4fD-3glqA:56.9 | 1d4fD-3glqA:56.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IOL_A_ESTA400_1 (ESTROGENIC 17-BETAHYDROXYSTEROIDDEHYDROGENASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 11 | SER A 241GLY A 393LEU A 388GLY A 237GLU A 199 | NoneRAB A 602 ( 3.8A)RAB A 602 ( 4.7A)NoneRAB A 602 (-4.6A) | 1.36A | 1iolA-3glqA:7.3 | 1iolA-3glqA:24.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIA_D_SAMD3293_0 (GLYCINEN-METHYLTRANSFERASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | GLY A 59ASP A 139ALA A 133LEU A 190TYR A 117 | NoneRAB A 602 (-3.0A)NoneNoneNone | 1.40A | 1kiaD-3glqA:undetectable | 1kiaD-3glqA:22.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V8B_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.24A | 1v8bA-3glqA:57.4 | 1v8bA-3glqA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V8B_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.32A | 1v8bA-3glqA:57.4 | 1v8bA-3glqA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V8B_B_ADNB1502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.20A | 1v8bB-3glqA:57.1 | 1v8bB-3glqA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V8B_B_ADNB1502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.31A | 1v8bB-3glqA:57.1 | 1v8bB-3glqA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V8B_C_ADNC2502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.23A | 1v8bC-3glqA:57.5 | 1v8bC-3glqA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V8B_C_ADNC2502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.31A | 1v8bC-3glqA:57.5 | 1v8bC-3glqA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V8B_D_ADND3502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.22A | 1v8bD-3glqA:29.8 | 1v8bD-3glqA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1V8B_D_ADND3502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.33A | 1v8bD-3glqA:29.8 | 1v8bD-3glqA:51.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_A_ADNA433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | ASP A 233LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 1.00A | 1xwfA-3glqA:52.8 | 1xwfA-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_A_ADNA433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 344LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 ( 3.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 0.70A | 1xwfA-3glqA:52.8 | 1xwfA-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_A_ADNA433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 344LEU A 388GLY A 393MET A 399PHE A 403 | RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.69A | 1xwfA-3glqA:52.8 | 1xwfA-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_A_ADNA433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 385PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)None | 1.30A | 1xwfA-3glqA:52.8 | 1xwfA-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_A_ADNA433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 388GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.91A | 1xwfA-3glqA:52.8 | 1xwfA-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_A_ADNA433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | LEU A 61HIS A 62THR A 64ASP A 139ASP A 233GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.76A | 1xwfA-3glqA:52.8 | 1xwfA-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_A_ADNA433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | THR A 64HIS A 344GLY A 393MET A 399PHE A 403 | RAB A 602 (-2.7A)RAB A 602 ( 3.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.77A | 1xwfA-3glqA:52.8 | 1xwfA-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_B_ADNB433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | ASP A 233LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 1.03A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_B_ADNB433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 344LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 ( 3.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 0.69A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_B_ADNB433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 344LEU A 388GLY A 393MET A 399PHE A 403 | RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.68A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_B_ADNB433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 385PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)None | 1.28A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_B_ADNB433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 388GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.96A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_B_ADNB433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | LEU A 61HIS A 62THR A 64ASP A 139ASP A 233GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.79A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_B_ADNB433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | THR A 64HIS A 344GLY A 393MET A 399PHE A 403 | RAB A 602 (-2.7A)RAB A 602 ( 3.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.73A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_B_ADNB433_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 3 / 3 | THR A 67GLU A 199HIS A 394 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 3.6A) | 0.81A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_C_ADNC433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | ASP A 233LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 1.01A | 1xwfC-3glqA:52.7 | 1xwfC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_C_ADNC433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 344LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 ( 3.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 0.71A | 1xwfC-3glqA:52.7 | 1xwfC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_C_ADNC433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 344LEU A 388GLY A 393MET A 399PHE A 403 | RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.70A | 1xwfC-3glqA:52.7 | 1xwfC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_C_ADNC433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 385PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)None | 1.27A | 1xwfC-3glqA:52.7 | 1xwfC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_C_ADNC433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 388GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.94A | 1xwfC-3glqA:52.7 | 1xwfC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_C_ADNC433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | LEU A 61HIS A 62THR A 64ASP A 139ASP A 233GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.79A | 1xwfC-3glqA:52.7 | 1xwfC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_C_ADNC433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | THR A 64HIS A 344GLY A 393MET A 399PHE A 403 | RAB A 602 (-2.7A)RAB A 602 ( 3.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.79A | 1xwfC-3glqA:52.7 | 1xwfC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_C_ADNC433_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 3 / 3 | THR A 67GLU A 199HIS A 394 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 3.6A) | 0.82A | 1xwfC-3glqA:52.7 | 1xwfC-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_D_ADND433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | ASP A 233LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 1.02A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_D_ADND433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 344LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 ( 3.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 0.73A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_D_ADND433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 344LEU A 388GLY A 393MET A 399PHE A 403 | RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.73A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_D_ADND433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 385PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)None | 1.27A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_D_ADND433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 388GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.98A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_D_ADND433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | LEU A 61HIS A 62THR A 64ASP A 139ASP A 233GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.81A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_D_ADND433_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | THR A 64HIS A 344GLY A 393MET A 399PHE A 403 | RAB A 602 (-2.7A)RAB A 602 ( 3.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.79A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XWF_D_ADND433_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 3 / 3 | THR A 67GLU A 199HIS A 394 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 3.6A) | 0.83A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VN1_A_FK5A501_2 (70 KDAPEPTIDYLPROLYLISOMERASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 6 | LEU A 61SER A 226ASP A 432GLU A 199 | NoneNoneNoneRAB A 602 (-4.6A) | 1.11A | 2vn1B-3glqA:undetectable | 2vn1B-3glqA:14.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_A_2FAA500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.39A | 2zj0A-3glqA:58.7 | 2zj0A-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_A_2FAA500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.37A | 2zj0A-3glqA:58.7 | 2zj0A-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_A_2FAA500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.47A | 2zj0A-3glqA:58.7 | 2zj0A-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_A_2FAA500_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200HIS A 344LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A) | 0.30A | 2zj0A-3glqA:58.7 | 2zj0A-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_B_2FAB500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.48A | 2zj0B-3glqA:58.7 | 2zj0B-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_B_2FAB500_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | LEU A 61GLN A 66THR A 67THR A 200HIS A 344 | NoneRAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A) | 0.34A | 2zj0B-3glqA:58.7 | 2zj0B-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_C_2FAC500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A) | 1.36A | 2zj0C-3glqA:58.6 | 2zj0C-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_C_2FAC500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.47A | 2zj0C-3glqA:58.6 | 2zj0C-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_C_2FAC500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139LEU A 385MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 4.1A)RAB A 602 (-3.6A) | 1.46A | 2zj0C-3glqA:58.6 | 2zj0C-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_C_2FAC500_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | LEU A 61GLN A 66THR A 67THR A 200HIS A 344 | NoneRAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A) | 0.17A | 2zj0C-3glqA:58.6 | 2zj0C-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_D_2FAD500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.36A | 2zj0D-3glqA:58.7 | 2zj0D-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_D_2FAD500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233HIS A 344LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.44A | 2zj0D-3glqA:58.7 | 2zj0D-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_D_2FAD500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A) | 1.30A | 2zj0D-3glqA:58.7 | 2zj0D-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZJ0_D_2FAD500_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | LEU A 61GLN A 66THR A 67THR A 200 | NoneRAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A) | 0.28A | 2zj0D-3glqA:58.7 | 2zj0D-3glqA:57.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_A_ADNA500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.38A | 3ce6A-3glqA:59.0 | 3ce6A-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_A_ADNA500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.50A | 3ce6A-3glqA:59.0 | 3ce6A-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_A_ADNA500_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200HIS A 344LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A) | 0.19A | 3ce6A-3glqA:59.0 | 3ce6A-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_B_ADNB500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.39A | 3ce6B-3glqA:59.2 | 3ce6B-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_B_ADNB500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.50A | 3ce6B-3glqA:59.2 | 3ce6B-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_B_ADNB500_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | LEU A 61GLN A 66THR A 67THR A 200HIS A 344 | NoneRAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A) | 0.15A | 3ce6B-3glqA:59.2 | 3ce6B-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_C_ADNC500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.36A | 3ce6C-3glqA:59.1 | 3ce6C-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_C_ADNC500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.49A | 3ce6C-3glqA:59.1 | 3ce6C-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_C_ADNC500_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200HIS A 344LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A) | 0.24A | 3ce6C-3glqA:59.1 | 3ce6C-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_D_ADND500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.37A | 3ce6D-3glqA:59.1 | 3ce6D-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_D_ADND500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.49A | 3ce6D-3glqA:59.1 | 3ce6D-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_D_ADND500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.39A | 3ce6D-3glqA:59.1 | 3ce6D-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CE6_D_ADND500_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | LEU A 61GLN A 66THR A 67HIS A 344LEU A 385 | NoneRAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A) | 0.24A | 3ce6D-3glqA:59.1 | 3ce6D-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G1U_A_ADNA438_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | LEU A 61ASP A 139GLU A 199ASN A 234LEU A 388 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 (-3.5A)RAB A 602 ( 4.7A) | 1.43A | 3g1uA-3glqA:55.6 | 3g1uA-3glqA:55.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G1U_A_ADNA438_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199ASN A 234LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 (-3.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.71A | 3g1uA-3glqA:55.6 | 3g1uA-3glqA:55.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G1U_A_ADNA438_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67THR A 200HIS A 344 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A) | 0.20A | 3g1uA-3glqA:55.6 | 3g1uA-3glqA:55.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G1U_B_ADNB438_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64GLN A 66ASP A 139THR A 200LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.25A | 3g1uB-3glqA:55.7 | 3g1uB-3glqA:55.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G1U_B_ADNB438_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 3 / 3 | THR A 67GLU A 199HIS A 344 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)RAB A 602 ( 3.5A) | 0.44A | 3g1uB-3glqA:55.7 | 3g1uB-3glqA:55.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G1U_C_ADNC438_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.11A | 3g1uC-3glqA:56.4 | 3g1uC-3glqA:55.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G1U_C_ADNC438_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.42A | 3g1uC-3glqA:56.4 | 3g1uC-3glqA:55.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G1U_C_ADNC438_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200HIS A 344HIS A 394 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 ( 3.6A) | 0.20A | 3g1uC-3glqA:56.4 | 3g1uC-3glqA:55.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G1U_D_ADND438_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139THR A 200ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.31A | 3g1uD-3glqA:56.2 | 3g1uD-3glqA:55.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G1U_D_ADND438_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139THR A 200ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.29A | 3g1uD-3glqA:56.2 | 3g1uD-3glqA:55.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G1U_D_ADND438_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67GLU A 199HIS A 344 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-4.6A)RAB A 602 ( 3.5A) | 0.53A | 3g1uD-3glqA:56.2 | 3g1uD-3glqA:55.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H9U_A_ADNA439_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 10 / 10 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.18A | 3h9uA-3glqA:58.4 | 3h9uA-3glqA:57.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H9U_B_ADNB438_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 10 / 10 | HIS A 62THR A 64GLN A 66THR A 67ASN A 387LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 (-3.0A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.19A | 3h9uB-3glqA:58.1 | 3h9uB-3glqA:57.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H9U_C_ADNC438_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 10 / 10 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.16A | 3h9uC-3glqA:58.5 | 3h9uC-3glqA:57.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H9U_D_ADND438_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 10 / 10 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.17A | 3h9uD-3glqA:58.6 | 3h9uD-3glqA:57.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ID6_C_SAMC301_0 (FIBRILLARIN-LIKERRNA/TRNA2'-O-METHYLTRANSFERASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | GLY A 59THR A 67SER A 121ALA A 133ILE A 136 | NoneRAB A 602 (-4.5A)NoneNoneNone | 1.11A | 3id6C-3glqA:5.9 | 3id6C-3glqA:17.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_A_ADNA500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.34A | 3n58A-3glqA:62.4 | 3n58A-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_A_ADNA500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 388 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.02A | 3n58A-3glqA:62.4 | 3n58A-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_A_ADNA500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.20A | 3n58A-3glqA:62.4 | 3n58A-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_A_ADNA500_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67GLU A 199THR A 200HIS A 344 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A) | 0.49A | 3n58A-3glqA:62.4 | 3n58A-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_C_ADNC500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | HIS A 62ASP A 139THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.39A | 3n58C-3glqA:62.5 | 3n58C-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_C_ADNC500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139THR A 200LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.20A | 3n58C-3glqA:62.5 | 3n58C-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_C_ADNC500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.41A | 3n58C-3glqA:62.5 | 3n58C-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_C_ADNC500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | THR A 67ASP A 139THR A 200ASP A 233LEU A 388 | RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.40A | 3n58C-3glqA:62.5 | 3n58C-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_C_ADNC500_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | LEU A 61GLN A 66THR A 67GLU A 199HIS A 344 | NoneRAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-4.6A)RAB A 602 ( 3.5A) | 0.49A | 3n58C-3glqA:62.5 | 3n58C-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_D_ADND500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.43A | 3n58D-3glqA:62.2 | 3n58D-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_D_ADND500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | LEU A 61HIS A 62ASP A 139THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.31A | 3n58D-3glqA:62.2 | 3n58D-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_D_ADND500_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139THR A 200LYS A 229ASP A 233LEU A 385LEU A 388HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.23A | 3n58D-3glqA:62.2 | 3n58D-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N58_D_ADND500_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67GLU A 199HIS A 344 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-4.6A)RAB A 602 ( 3.5A) | 0.53A | 3n58D-3glqA:62.2 | 3n58D-3glqA:67.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OND_A_ADNA506_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.27A | 3ondA-3glqA:57.7 | 3ondA-3glqA:57.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OND_A_ADNA506_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.39A | 3ondA-3glqA:57.7 | 3ondA-3glqA:57.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OND_A_ADNA506_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.42A | 3ondA-3glqA:57.7 | 3ondA-3glqA:57.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OND_A_ADNA506_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 3 / 3 | GLN A 66THR A 67LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 4.1A) | 0.60A | 3ondA-3glqA:57.7 | 3ondA-3glqA:57.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OND_B_ADNB507_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.28A | 3ondB-3glqA:56.9 | 3ondB-3glqA:57.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OND_B_ADNB507_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.39A | 3ondB-3glqA:56.9 | 3ondB-3glqA:57.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OND_B_ADNB507_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.42A | 3ondB-3glqA:56.9 | 3ondB-3glqA:57.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OND_B_ADNB507_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 3 / 3 | GLN A 66THR A 67LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 4.1A) | 0.62A | 3ondB-3glqA:56.9 | 3ondB-3glqA:57.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BLV_A_SAMA1281_1 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE J) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 6 | HIS A 344SER A 60ASP A 115ASP A 142 | RAB A 602 ( 3.5A)NoneNoneNone | 1.33A | 4blvA-3glqA:4.8 | 4blvA-3glqA:20.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LVC_A_ADNA501_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE)) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.24A | 4lvcA-3glqA:61.3 | 4lvcA-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LVC_A_ADNA501_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE)) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.36A | 4lvcA-3glqA:61.3 | 4lvcA-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LVC_A_ADNA501_2 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE)) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200HIS A 344LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A) | 0.50A | 4lvcA-3glqA:61.3 | 4lvcA-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LVC_B_ADNB501_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE)) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.32A | 4lvcB-3glqA:61.1 | 4lvcB-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LVC_B_ADNB501_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE)) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233HIS A 344GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.38A | 4lvcB-3glqA:61.1 | 4lvcB-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LVC_B_ADNB501_2 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE)) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200LEU A 385LEU A 388 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A) | 0.51A | 4lvcB-3glqA:61.1 | 4lvcB-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LVC_C_ADNC501_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE)) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.36A | 4lvcC-3glqA:61.5 | 4lvcC-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LVC_C_ADNC501_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE)) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | LEU A 61HIS A 62ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.29A | 4lvcC-3glqA:61.5 | 4lvcC-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LVC_C_ADNC501_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE)) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.35A | 4lvcC-3glqA:61.5 | 4lvcC-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LVC_C_ADNC501_2 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE)) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200HIS A 344LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A) | 0.50A | 4lvcC-3glqA:61.5 | 4lvcC-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PFJ_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.32A | 4pfjA-3glqA:59.8 | 4pfjA-3glqA:56.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PFJ_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.40A | 4pfjA-3glqA:59.8 | 4pfjA-3glqA:56.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PFJ_A_ADNA502_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 7 | THR A 67THR A 200HIS A 344LEU A 385ASN A 387SER A 402 | RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A)NAD A 601 (-3.0A)None | 0.32A | 4pfjA-3glqA:59.8 | 4pfjA-3glqA:56.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PFJ_B_ADNB502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.16A | 4pfjB-3glqA:58.7 | 4pfjB-3glqA:56.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PFJ_B_ADNB502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 9 / 12 | HIS A 62THR A 64ASP A 139LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.65A | 4pfjB-3glqA:58.7 | 4pfjB-3glqA:56.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PFJ_B_ADNB502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | HIS A 62THR A 64GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.48A | 4pfjB-3glqA:58.7 | 4pfjB-3glqA:56.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PFJ_B_ADNB502_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 6 | THR A 67GLN A 92THR A 200HIS A 344ASN A 387 | RAB A 602 (-4.5A)NoneNAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 (-3.0A) | 0.42A | 4pfjB-3glqA:58.7 | 4pfjB-3glqA:56.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PGF_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385ASN A 387GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 (-3.0A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.51A | 4pgfA-3glqA:58.9 | 4pgfA-3glqA:56.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PGF_A_ADNA502_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 6 | THR A 64THR A 67THR A 200HIS A 344LEU A 388 | RAB A 602 (-2.7A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A) | 0.25A | 4pgfA-3glqA:58.9 | 4pgfA-3glqA:56.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PGF_B_ADNB502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | HIS A 62ASP A 139LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.68A | 4pgfB-3glqA:58.2 | 4pgfB-3glqA:56.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PGF_B_ADNB502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 10 / 12 | HIS A 62GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.54A | 4pgfB-3glqA:58.2 | 4pgfB-3glqA:56.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PGF_B_ADNB502_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | THR A 64THR A 67THR A 200HIS A 344ASN A 387 | RAB A 602 (-2.7A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 (-3.0A) | 0.31A | 4pgfB-3glqA:58.2 | 4pgfB-3glqA:56.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PGH_B_SAMB401_0 (CAFFEIC ACIDO-METHYLTRANSFERASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | SER A 90ASP A 139GLY A 140ASP A 142LEU A 145 | NoneRAB A 602 (-3.0A)NoneNoneNone | 1.35A | 4pghB-3glqA:2.8 | 4pghB-3glqA:22.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AXA_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.27A | 5axaA-3glqA:59.1 | 5axaA-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AXA_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.37A | 5axaA-3glqA:59.1 | 5axaA-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AXA_C_ADNC502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.29A | 5axaC-3glqA:59.0 | 5axaC-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AXA_C_ADNC502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.37A | 5axaC-3glqA:59.0 | 5axaC-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AXD_A_RBVA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.26A | 5axdA-3glqA:59.0 | 5axdA-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AXD_A_RBVA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | HIS A 62THR A 64ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A) | 0.40A | 5axdA-3glqA:59.0 | 5axdA-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AXD_A_RBVA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A) | 1.36A | 5axdA-3glqA:59.0 | 5axdA-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AXD_C_RBVC502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.28A | 5axdC-3glqA:59.0 | 5axdC-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AXD_C_RBVC502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | HIS A 62THR A 64ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A) | 0.39A | 5axdC-3glqA:59.0 | 5axdC-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AXD_C_RBVC502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.40A | 5axdC-3glqA:59.0 | 5axdC-3glqA:57.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_A_ADNA501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.34A | 5hm8A-3glqA:55.0 | 5hm8A-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_A_ADNA501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.23A | 5hm8A-3glqA:55.0 | 5hm8A-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_A_ADNA501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233HIS A 344LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.24A | 5hm8A-3glqA:55.0 | 5hm8A-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_A_ADNA501_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 5 | THR A 67GLU A 199THR A 200LEU A 385 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.68A | 5hm8A-3glqA:55.0 | 5hm8A-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_B_ADNB501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.34A | 5hm8B-3glqA:55.0 | 5hm8B-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_B_ADNB501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.24A | 5hm8B-3glqA:55.0 | 5hm8B-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_B_ADNB501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233HIS A 344LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.23A | 5hm8B-3glqA:55.0 | 5hm8B-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_B_ADNB501_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 5 | THR A 67GLU A 199THR A 200LEU A 385 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.68A | 5hm8B-3glqA:55.0 | 5hm8B-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_C_ADNC501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.34A | 5hm8C-3glqA:55.7 | 5hm8C-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_C_ADNC501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.23A | 5hm8C-3glqA:55.7 | 5hm8C-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_C_ADNC501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233HIS A 344LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.23A | 5hm8C-3glqA:55.7 | 5hm8C-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_C_ADNC501_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 5 | THR A 67GLU A 199THR A 200LEU A 385 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.68A | 5hm8C-3glqA:55.7 | 5hm8C-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_D_ADND501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.34A | 5hm8D-3glqA:55.2 | 5hm8D-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_D_ADND501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.23A | 5hm8D-3glqA:55.2 | 5hm8D-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_D_ADND501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233HIS A 344LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.24A | 5hm8D-3glqA:55.2 | 5hm8D-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_D_ADND501_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 5 | THR A 67GLU A 199THR A 200LEU A 385 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.68A | 5hm8D-3glqA:55.2 | 5hm8D-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_E_ADNE501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.34A | 5hm8E-3glqA:55.5 | 5hm8E-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_E_ADNE501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.23A | 5hm8E-3glqA:55.5 | 5hm8E-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_E_ADNE501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233HIS A 344LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.24A | 5hm8E-3glqA:55.5 | 5hm8E-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_E_ADNE501_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 5 | THR A 67GLU A 199THR A 200LEU A 385 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.68A | 5hm8E-3glqA:55.5 | 5hm8E-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_F_ADNF501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.34A | 5hm8F-3glqA:55.1 | 5hm8F-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_F_ADNF501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.23A | 5hm8F-3glqA:55.1 | 5hm8F-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_F_ADNF501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233HIS A 344LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.23A | 5hm8F-3glqA:55.1 | 5hm8F-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_F_ADNF501_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 5 | THR A 67GLU A 199THR A 200LEU A 385 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.67A | 5hm8F-3glqA:55.1 | 5hm8F-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_G_ADNG501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.34A | 5hm8G-3glqA:55.0 | 5hm8G-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_G_ADNG501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.24A | 5hm8G-3glqA:55.0 | 5hm8G-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_G_ADNG501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233HIS A 344LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.24A | 5hm8G-3glqA:55.0 | 5hm8G-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_G_ADNG501_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 5 | THR A 67GLU A 199THR A 200LEU A 385 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.78A | 5hm8G-3glqA:55.0 | 5hm8G-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_H_ADNH501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.34A | 5hm8H-3glqA:55.7 | 5hm8H-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_H_ADNH501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.24A | 5hm8H-3glqA:55.7 | 5hm8H-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_H_ADNH501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233HIS A 344LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.24A | 5hm8H-3glqA:55.7 | 5hm8H-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HM8_H_ADNH501_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 5 | THR A 67GLU A 199THR A 200LEU A 385 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.68A | 5hm8H-3glqA:55.7 | 5hm8H-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5K_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.23A | 5m5kA-3glqA:60.5 | 5m5kA-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5K_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.36A | 5m5kA-3glqA:60.5 | 5m5kA-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5K_A_ADNA502_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67THR A 200LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.57A | 5m5kA-3glqA:60.5 | 5m5kA-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5K_B_ADNB502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A) | 1.34A | 5m5kB-3glqA:60.5 | 5m5kB-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5K_B_ADNB502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199THR A 200LYS A 229ASP A 233GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.45A | 5m5kB-3glqA:60.5 | 5m5kB-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5K_B_ADNB502_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67LEU A 385LEU A 388 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A) | 0.55A | 5m5kB-3glqA:60.5 | 5m5kB-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5K_C_ADNC502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.24A | 5m5kC-3glqA:60.6 | 5m5kC-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5K_C_ADNC502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.35A | 5m5kC-3glqA:60.6 | 5m5kC-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5K_C_ADNC502_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67THR A 200LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.57A | 5m5kC-3glqA:60.6 | 5m5kC-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.38A | 5m66A-3glqA:61.3 | 5m66A-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.29A | 5m66A-3glqA:61.3 | 5m66A-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.24A | 5m66A-3glqA:61.3 | 5m66A-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_A_ADNA502_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67GLU A 199LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 4.1A) | 0.66A | 5m66A-3glqA:61.3 | 5m66A-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_B_ADNB502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.36A | 5m66B-3glqA:61.3 | 5m66B-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_B_ADNB502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.22A | 5m66B-3glqA:61.3 | 5m66B-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_B_ADNB502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.36A | 5m66B-3glqA:61.3 | 5m66B-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_B_ADNB502_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67THR A 200LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.52A | 5m66B-3glqA:61.3 | 5m66B-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_C_ADNC502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.37A | 5m66C-3glqA:61.3 | 5m66C-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_C_ADNC502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64GLN A 66ASP A 139THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.23A | 5m66C-3glqA:61.3 | 5m66C-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_C_ADNC502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.41A | 5m66C-3glqA:61.3 | 5m66C-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_D_ADND502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | HIS A 62ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.37A | 5m66D-3glqA:60.9 | 5m66D-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_D_ADND502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64GLN A 66ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.39A | 5m66D-3glqA:60.9 | 5m66D-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_D_ADND502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.39A | 5m66D-3glqA:60.9 | 5m66D-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M66_D_ADND502_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 3 / 3 | THR A 67THR A 200LEU A 385 | RAB A 602 (-4.5A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.69A | 5m66D-3glqA:60.9 | 5m66D-3glqA:65.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UTU_F_ADNF503_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.28A | 5utuF-3glqA:55.5 | 5utuF-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UTU_F_ADNF503_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.36A | 5utuF-3glqA:55.5 | 5utuF-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UTU_F_ADNF503_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.28A | 5utuF-3glqA:55.5 | 5utuF-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UTU_F_ADNF503_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | THR A 201LYS A 229ASP A 233LEU A 385HIS A 394 | NAD A 601 (-3.1A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.21A | 5utuF-3glqA:55.5 | 5utuF-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UTU_H_ADNH503_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.36A | 5utuH-3glqA:55.9 | 5utuH-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UTU_H_ADNH503_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.25A | 5utuH-3glqA:55.9 | 5utuH-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UTU_H_ADNH503_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | LEU A 61HIS A 62THR A 64ASP A 139LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.23A | 5utuH-3glqA:55.9 | 5utuH-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UTU_H_ADNH503_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 5 | THR A 67GLU A 199THR A 200LEU A 385 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.74A | 5utuH-3glqA:55.9 | 5utuH-3glqA:50.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V96_A_ADNA502_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.25A | 5v96A-3glqA:59.4 | 5v96A-3glqA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V96_A_ADNA502_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.41A | 5v96A-3glqA:59.4 | 5v96A-3glqA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V96_B_ADNB502_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.29A | 5v96B-3glqA:59.6 | 5v96B-3glqA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V96_B_ADNB502_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.41A | 5v96B-3glqA:59.6 | 5v96B-3glqA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V96_B_ADNB502_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.40A | 5v96B-3glqA:59.6 | 5v96B-3glqA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V96_C_ADNC502_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.27A | 5v96C-3glqA:59.7 | 5v96C-3glqA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V96_C_ADNC502_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.39A | 5v96C-3glqA:59.7 | 5v96C-3glqA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V96_C_ADNC502_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.40A | 5v96C-3glqA:59.7 | 5v96C-3glqA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V96_D_ADND502_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.40A | 5v96D-3glqA:59.6 | 5v96D-3glqA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V96_D_ADND502_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.25A | 5v96D-3glqA:59.6 | 5v96D-3glqA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V96_D_ADND502_1 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.41A | 5v96D-3glqA:59.6 | 5v96D-3glqA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6APH_A_ADNA501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.39A | 6aphA-3glqA:58.9 | 6aphA-3glqA:58.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6APH_A_ADNA501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | LEU A 61ASP A 139LYS A 229ASP A 233LEU A 388HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A) | 1.36A | 6aphA-3glqA:58.9 | 6aphA-3glqA:58.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6APH_A_ADNA501_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.35A | 6aphA-3glqA:58.9 | 6aphA-3glqA:58.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6APH_A_ADNA501_2 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200HIS A 344LEU A 388 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A) | 0.19A | 6aphA-3glqA:58.9 | 6aphA-3glqA:58.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_A_ADNA502_0 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | HIS A 62THR A 64GLN A 66THR A 67ASP A 233ASN A 387LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-2.5A)NAD A 601 (-3.0A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.27A | 6exiA-3glqA:60.2 | 6exiA-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_A_ADNA502_0 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | HIS A 62THR A 64GLN A 66THR A 67HIS A 344LEU A 388GLY A 393PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)None | 1.00A | 6exiA-3glqA:60.2 | 6exiA-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_B_ADNB502_0 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | HIS A 62THR A 64GLN A 66THR A 67HIS A 344LEU A 388PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)None | 1.03A | 6exiB-3glqA:59.0 | 6exiB-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_B_ADNB502_0 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | HIS A 62THR A 64GLN A 66THR A 67LYS A 229ASP A 233ASN A 387LEU A 388HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 (-3.0A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.64A | 6exiB-3glqA:59.0 | 6exiB-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_C_ADNC502_0 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 64ASP A 233ASN A 234LEU A 385 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-2.5A)NAD A 601 (-3.5A)NAD A 601 ( 4.1A) | 1.24A | 6exiC-3glqA:60.3 | 6exiC-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_C_ADNC502_0 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | LEU A 61HIS A 62ASP A 233ASN A 234LEU A 385 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.5A)NAD A 601 (-3.5A)NAD A 601 ( 4.1A) | 1.32A | 6exiC-3glqA:60.3 | 6exiC-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_C_ADNC502_0 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 8 / 12 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67ASP A 233ASN A 234MET A 399 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-2.5A)NAD A 601 (-3.5A)RAB A 602 (-3.6A) | 0.80A | 6exiC-3glqA:60.3 | 6exiC-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_C_ADNC502_0 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 10 / 12 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67ASP A 233ASN A 387LEU A 388HIS A 394MET A 399 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-2.5A)NAD A 601 (-3.0A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A) | 0.28A | 6exiC-3glqA:60.3 | 6exiC-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_C_ADNC502_0 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67HIS A 344LEU A 388 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A) | 0.98A | 6exiC-3glqA:60.3 | 6exiC-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_C_ADNC502_1 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 3 / 3 | LEU A 385GLY A 393PHE A 403 | NAD A 601 ( 4.1A)RAB A 602 ( 3.8A)None | 0.56A | 6exiC-3glqA:60.3 | 6exiC-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_D_ADND502_0 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 11 / 12 | HIS A 62THR A 64GLN A 66THR A 67ASP A 233ASN A 387LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-2.5A)NAD A 601 (-3.0A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.33A | 6exiD-3glqA:59.2 | 6exiD-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EXI_D_ADND502_0 (ADENOSYLHOMOCYSTEINASE) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 9 / 12 | HIS A 62THR A 64GLN A 66THR A 67HIS A 344LEU A 388GLY A 393MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 1.05A | 6exiD-3glqA:59.2 | 6exiD-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_A_ADNA502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | HIS A 62ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388HIS A 394 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A) | 1.44A | 6f3mA-3glqA:53.9 | 6f3mA-3glqA:51.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_A_ADNA502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233HIS A 344LEU A 385GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.40A | 6f3mA-3glqA:53.9 | 6f3mA-3glqA:51.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_A_ADNA502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A) | 1.29A | 6f3mA-3glqA:53.9 | 6f3mA-3glqA:51.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_A_ADNA502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233LEU A 388 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.45A | 6f3mA-3glqA:53.9 | 6f3mA-3glqA:51.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_A_ADNA502_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67THR A 200LEU A 388 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 4.7A) | 0.13A | 6f3mA-3glqA:53.9 | 6f3mA-3glqA:51.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_B_ADNB502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.30A | 6f3mB-3glqA:53.9 | 6f3mB-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_B_ADNB502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233HIS A 344LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.39A | 6f3mB-3glqA:53.9 | 6f3mB-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_B_ADNB502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.32A | 6f3mB-3glqA:53.9 | 6f3mB-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_B_ADNB502_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67THR A 200LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.48A | 6f3mB-3glqA:53.9 | 6f3mB-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_C_ADNC502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | HIS A 62ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388HIS A 394 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A) | 1.45A | 6f3mC-3glqA:53.8 | 6f3mC-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_C_ADNC502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233HIS A 344LEU A 385GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.41A | 6f3mC-3glqA:53.8 | 6f3mC-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_C_ADNC502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.32A | 6f3mC-3glqA:53.8 | 6f3mC-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_C_ADNC502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233LEU A 388 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.45A | 6f3mC-3glqA:53.8 | 6f3mC-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_C_ADNC502_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67THR A 200LEU A 388 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 4.7A) | 0.13A | 6f3mC-3glqA:53.8 | 6f3mC-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_D_ADND502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.30A | 6f3mD-3glqA:53.9 | 6f3mD-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_D_ADND502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233HIS A 344LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.39A | 6f3mD-3glqA:53.9 | 6f3mD-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_D_ADND502_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62THR A 67ASP A 139ASP A 233HIS A 344MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.6A) | 1.31A | 6f3mD-3glqA:53.9 | 6f3mD-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3M_D_ADND502_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 5 | GLN A 66THR A 67THR A 200LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)NAD A 601 ( 4.1A) | 0.50A | 6f3mD-3glqA:53.9 | 6f3mD-3glqA:50.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_A_ADNA505_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.37A | 6f3nA-3glqA:54.0 | 6f3nA-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_A_ADNA505_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.37A | 6f3nA-3glqA:54.0 | 6f3nA-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_A_ADNA505_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67THR A 200HIS A 344 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A) | 0.14A | 6f3nA-3glqA:54.0 | 6f3nA-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_B_ADNB505_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.30A | 6f3nB-3glqA:54.1 | 6f3nB-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_B_ADNB505_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.37A | 6f3nB-3glqA:54.1 | 6f3nB-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_B_ADNB505_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A) | 1.34A | 6f3nB-3glqA:54.1 | 6f3nB-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_B_ADNB505_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67HIS A 344LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A) | 0.51A | 6f3nB-3glqA:54.1 | 6f3nB-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_C_ADNC505_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | HIS A 62ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388HIS A 394 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A) | 1.44A | 6f3nC-3glqA:54.1 | 6f3nC-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_C_ADNC505_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.38A | 6f3nC-3glqA:54.1 | 6f3nC-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_C_ADNC505_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233LEU A 388 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.43A | 6f3nC-3glqA:54.1 | 6f3nC-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_C_ADNC505_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.38A | 6f3nC-3glqA:54.1 | 6f3nC-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_C_ADNC505_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67THR A 200HIS A 344 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A) | 0.14A | 6f3nC-3glqA:54.1 | 6f3nC-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_D_ADND506_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.29A | 6f3nD-3glqA:54.0 | 6f3nD-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_D_ADND506_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.37A | 6f3nD-3glqA:54.0 | 6f3nD-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6F3N_D_ADND506_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 4 | GLN A 66THR A 67THR A 200HIS A 344 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A) | 0.12A | 6f3nD-3glqA:54.0 | 6f3nD-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_A_ADNA501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.25A | 6gbnA-3glqA:58.3 | 6gbnA-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_A_ADNA501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.39A | 6gbnA-3glqA:58.3 | 6gbnA-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_A_ADNA501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.32A | 6gbnA-3glqA:58.3 | 6gbnA-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_A_ADNA501_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200HIS A 344LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A) | 0.53A | 6gbnA-3glqA:58.3 | 6gbnA-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_B_ADNB501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 6 / 12 | HIS A 62ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.38A | 6gbnB-3glqA:57.9 | 6gbnB-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_B_ADNB501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.40A | 6gbnB-3glqA:57.9 | 6gbnB-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_B_ADNB501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.39A | 6gbnB-3glqA:57.9 | 6gbnB-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_B_ADNB501_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200HIS A 344LEU A 388 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A) | 0.17A | 6gbnB-3glqA:57.9 | 6gbnB-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_C_ADNC501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62ASP A 139LYS A 229ASP A 233LEU A 388 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.39A | 6gbnC-3glqA:58.4 | 6gbnC-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_C_ADNC501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.39A | 6gbnC-3glqA:58.4 | 6gbnC-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_C_ADNC501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.26A | 6gbnC-3glqA:58.4 | 6gbnC-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_C_ADNC501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.39A | 6gbnC-3glqA:58.4 | 6gbnC-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_C_ADNC501_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200HIS A 344GLY A 393 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)RAB A 602 ( 3.8A) | 0.17A | 6gbnC-3glqA:58.4 | 6gbnC-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_D_ADND501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 12 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.40A | 6gbnD-3glqA:57.8 | 6gbnD-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_D_ADND501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 7 / 12 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.23A | 6gbnD-3glqA:57.8 | 6gbnD-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_D_ADND501_1 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 12 / 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.33A | 6gbnD-3glqA:57.8 | 6gbnD-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6GBN_D_ADND501_2 (-) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 5 / 5 | GLN A 66THR A 67THR A 200HIS A 344LEU A 385 | RAB A 602 (-3.9A)RAB A 602 (-4.5A)NAD A 601 ( 2.9A)RAB A 602 ( 3.5A)NAD A 601 ( 4.1A) | 0.51A | 6gbnD-3glqA:57.8 | 6gbnD-3glqA:59.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GH9_A_MIXA1003_0 (UBIQUITINCARBOXYL-TERMINALHYDROLASE 15) |
3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) | 4 / 5 | ASN A 87GLY A 320HIS A 344ASP A 139 | NoneNAD A 601 (-3.5A)RAB A 602 ( 3.5A)RAB A 602 (-3.0A) | 1.06A | 6gh9A-3glqA:undetectable | 6gh9A-3glqA:10.68 |